What are some general thoughts you have on the clinical utility and value of high sensitivity troponin in patients when there is little clinical evidence for acute MI or acute decompensated heart failure, and lack of evidence to support non-ischemic myocardial injury?

How should we mitigate non-cardiologist consultant concerns about mildly elevated hsTrop levels of unclear significance?